The European Schizophrenia Cohort
- 390 Downloads
Schizophrenia has a variety of clinical profiles, disabilities and outcomes requiring responsive management and the devotion of considerable resources. The primary objective of the European Schizophrenia Cohort (EuroSC) is to relate the types of treatment and methods of care to clinical outcome. Secondary objectives include the assessment of treatment needs in relation to outcome, the calculation of resource consumption associated with different methods of care, and the identification of prognostic factors.
EuroSC is a naturalistic follow-up of a cohort of people aged 18 to 64 years, suffering from schizophrenia and in contact with secondary psychiatric services. The study was done in nine European centres, in France (N=288), Germany (N=618), and Britain (N=302). Participants were interviewed at 6-monthly intervals for a total of 2 years. This initial paper describes the methods used and presents clinical and social baseline data.
The clinical and socio-demographic differences between patients from the different countries were small. However, patients from Britain were considerably more likely than their continental counterparts to have a history of homelessness, rooflessness or imprisonment, even when social and clinical differences between the samples were controlled.
The samples were largely similar in clinical terms. Thus, the social differences between the samples seem likely to be due more to the societal context and may reflect relatively benign situations in the continental locations of our study.
This study was funded by an unrestricted research grant from Lundbeck A/S and a grant from the German Federal Ministry of Education and Research in the framework of the Research Association Public Health Saxony (grant no. 01EG9732/7). The first six authors of the paper received indirect support (in honoraria and travel funds) from Lundbeck A/S to participate in project management meetings. We are particularly grateful to the participants who gave of their time over the course of the study, and to the clinical teams who supported the project.
- 3.American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn, revised. American Psychiatric Association, Washington, DCGoogle Scholar
- 4.Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:276–672Google Scholar
- 9.Bebbington PE, Kuipers L (2003) Schizophrenia and psychosocial stresses. In: Hirsch SR, Weinberger D (eds) Schizophrenia. Blackwell, Oxford, pp 611–634Google Scholar
- 10.Beecham J, Knapp M (1992) Costing psychiatric interventions. In: Thornicroft G, Brewin CR, Wing JK (eds) Measuring mental health needs. Gaskell, LondonGoogle Scholar
- 11.Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D (1992) The posItive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. J Nerv Mental Disord 180:723–728Google Scholar
- 14.Chisholm D, Knapp M (2002) The economics of schizophrenia care in Europe: the EPSILON study. Epidemiol Psychiatr Soc 11:12–17Google Scholar
- 15.Cooper JE, Kendell RE, Gurland BJ, Sharpe L, Copeland JRM, Simon R (1972) Psychiatric diagnosis in New York and London. Maudsley Monograph No. 20. Oxford University Press, LondonGoogle Scholar
- 18.Gaite L, Vazquez-Barquero JL, Borra C, Ballesteros J, Schene A, Welcher B, Thornicroft G, Becker T, Ruggeri M, Herran A, Koeter M, Meijer K, Monden M, Sijsenaar M, Van-Wijngaarden B, Knudsen HC, Larsen A, Martiny K, Schou C, Beecham J, Brooks L, Chisholm D, Griffiths G, Grove J, Knapp M, Leese M, McCrone P, Padfield S, White IR, Arrizabalaga AA, Castanedo SH, Retuerto MP, Bourgon EV, Amaddeo F, Bisoffi G, Cristofalo D, Dall'Agnola R, Lasalvia A, Tansella M (2002) Quality of life in patients with schizophrenia in five European countries: the EPSILON study. Acta Psychiatr Scand 105:283–292CrossRefPubMedGoogle Scholar
- 19.Garratt AM, Ruta DA, Abdalla ME, Buckingham JK, Russell IT (1993) The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 306:1440–1444Google Scholar
- 21.Group for the Advancement of Psychiatry Committee on the Family (1996) Global Assessment of Relational Functioning Scale (GARF): I. Background and rationale. Group for the Advancement of Psychiatry Committee on the Family. Fam Proc 35:155–172Google Scholar
- 22.Guy W (1976) ECDEV Assessment manual for psychopharmacology. Revised DHEW Pub (AOM). National Institute for Mental Health, Rockville MDGoogle Scholar
- 25.Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. Br Med J 306:1437–1440Google Scholar
- 29.Kay SR, Opler LA, Lindenmayer JP (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 155:59–65Google Scholar
- 30.Kay SR (1991) Positive and negative syndromes in schizophrenia. Brunner/Mazel, New YorkGoogle Scholar
- 32.Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A, Thornicroft G, Vazquez-Barquero JL, Knudsen HC, Becker T (2002) EPSILON. European psychiatric services: inputs linked to outcome domains and needs: comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European psychiatric services: inputs linked to outcome domains and needs. Acta Psychiatr Scand 105:42–54CrossRefPubMedGoogle Scholar
- 38.Marwaha S, Johnson S, Bebbington P, Angermeyer M, Brugha T, Azorin J-M, Killian R, Hansen K, Toumi M (2005) Characteristics and correlates of employment in people with schizophrenia. Findings from the international EuroSC study. Br J Psychiatry (in press)Google Scholar
- 42.Overall JE, Gorham DR (1962) Brief Psychiatric Rating Scale. Psychol Rep 10:799–812Google Scholar
- 43.Phelan M, Slade M, Thornicroft G, Dunn G, Holloway F, Wykes T, Strathdee G, Loftus L, McCrone P, Hayward P (1995) The Camberwell Assessment of Need (CAN). The validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry 167:589–595PubMedGoogle Scholar
- 44.Psychopharmacology Research Branch NIMH (1976) Abnormal Involuntary Movement Scale (AIMS). In: Guy W (ed) Assessment manual for psychopharmacology (revised). NIMH, Rockville, MD, pp 534–537Google Scholar
- 45.Ruggeri M, Lasalvia A, Bisoffi G, Thornicroft G, Gazquez-Barquero JL, Becker T, Knapp M, Knudsen HC, Schene A, Tansella M (2003) Satisfaction with mental health services among people with schizophrenia in five European sites: results from the EPSILON study. Schizophr Bull 29:229–245PubMedGoogle Scholar
- 47.Sartorius N, Kuyken W (1994) Translation of health status instruments. In: Orley J, Kuyken W (eds) Quality of life assessment: international perspectives. Springer, Berlin Heidelberg New York, pp 2–18Google Scholar
- 49.Schene AH, Wijngaarden B (1992) The involvement evaluation questionnaire. Department of Psychiatry, University of Amsterdam, AmsterdamGoogle Scholar
- 53.Slade M, Loftus L, Phelan M, Thornicroft G, Wykes T (1999) The Camberwell assessment of need. Gaskell, LondonGoogle Scholar
- 57.van Agt HM, Essink-Bot ML, Krabbe PF, Bonsel GJ (1994) Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med 39:1437–1444Google Scholar
- 58.Van-Wijngaarden B, Schene A, Koeter M, Becker T, Knapp M, Knudsen HC, Tansella M, Thornicroft G, Vazquez-Barquero JL, Lasalvia A, Leese M (2003) People with schizophrenia in five countries: conceptual similarities and intercultural differences in family caregiving. Schizophr Bull 39:573–586Google Scholar
- 59.Walsh E, Buchanan A (2003) Criminal and violent behaviour in schizophrenia. In: Murray R, Jones P, Susser E, van Os J, Cannon M (eds) The epidemiology of schizophrenia. CUP, CambridgeGoogle Scholar
- 62.World Health Organization (1973) The international pilot study of schizophrenia. WHO, GenevaGoogle Scholar
- 63.World Health Organization (1992). SCAN: Schedules for Clinical Assessment in Neuropsychiatry. WHO, GenevaGoogle Scholar